What the Mounjaro® labels record instead
The US prescribing information builds its main table from two placebo-controlled diabetes trials (SURPASS-1 and SURPASS-5, 953 adults, average exposure 36.6 weeks) and lists reactions seen in at least 5% of people on Mounjaro® and more often than on placebo [1]. Hiccups are absent there and in the section on postmarketing reports. A smaller list of stomach effects that were more frequent than on placebo is given in the text, and that is where the nearest relatives of hiccups sit [1].
The European product information places dyspepsia, bloating of the abdomen, eructation (burping), flatulence and gastro-oesophageal reflux disease in its “common” band, and delayed gastric emptying in the “uncommon” band [3]. The Canadian monograph lists the same group among reactions in at least 1% of patients [4]. Neither mentions hiccups.
We searched PubMed on 20 October 2026 for tirzepatide and hiccups and found no trial report, case report or pharmacovigilance study on tirzepatide. For a different GLP-1 medicine, semaglutide, one review of FDA safety reports counted 47 hiccup reports [8]; that says nothing directly about tirzepatide. For Mounjaro® this is an absence of evidence, not proof that the two are unrelated.
| Reaction | Placebo | Mounjaro® 5 mg | Mounjaro® 10 mg | Mounjaro® 15 mg |
|---|---|---|---|---|
| Dyspepsia (indigestion) | 3% | 8% | 8% | 5% |
| Eructation (burping) | 0.4% | 3.0% | 2.5% | 3.3% |
| Gastroesophageal reflux disease | 0.4% | 1.7% | 2.5% | 1.7% |
| Abdominal distension | 0.4% | 0.4% | 2.9% | 0.8% |
| Flatulence | 0% | 1.3% | 2.5% | 2.9% |
A neighbouring label that does mention hiccups
Hiccups are not unknown in this family of medicines. The Wegovy® (semaglutide) label lists hiccups among the stomach reactions that occurred more often than on placebo in its adult weight-reduction trials, together with dyspepsia, burping and reflux, and says these were reported mostly while the dose was being raised [5].
That is a different molecule and a different trial population, so its finding cannot be transferred to Mounjaro®. It does suggest that when hiccups appear on a GLP-1-based medicine, they tend to travel with the upper-stomach effects rather than on their own.
How a slower stomach could lead to hiccups
What the label supports: tirzepatide delays gastric emptying, and the US label adds that the delay is largest after the first dose and diminishes over time [1]. It also reports that most nausea, vomiting and diarrhea happened during dose escalation and then decreased [1]. On the standard schedule, the dose goes up in 2.5 mg steps after at least four weeks on the current one, so each step is a new adjustment period [1].
What is plausible but unmeasured for Mounjaro®: hiccups are spasms of the diaphragm set off when the nerves that control it are irritated, and eating too much or too fast, swallowing air and fizzy drinks are recognised triggers [6]. A stomach that stays full for longer, together with burping and reflux, could provide that irritation. No study has tested this for tirzepatide.
Timing may give a hint. After an injection, tirzepatide reaches its highest level in the blood somewhere between 8 and 72 hours, and it has a half-life of about five days [1]. If hiccups cluster in the day or two after your shot or after a dose step, that is worth writing down.
Causes that have nothing to do with Mounjaro®
Most short bouts of hiccups have no identifiable cause, according to MedlinePlus [7]. Cleveland Clinic lists triggers for brief episodes such as large or rushed meals, spicy or very hot or cold food, carbonated drinks, alcohol and smoking [6].
Hiccups that last for days have a different list: reflux disease or gastritis, conditions of the brain and nerves such as stroke or multiple sclerosis, lung conditions such as pneumonia, metabolic problems including kidney failure (uremia) and low calcium, some infections, and certain medicines, including dexamethasone, some benzodiazepines and some chemotherapy drugs [6]. Persistent hiccups can also follow surgery under general anaesthesia [6]. This longer list is why lasting hiccups are examined rather than waited out.
What may ease them
Cleveland Clinic says no hiccup cure has been proven, though brief holding of the breath, sipping or gargling cold water, or breathing into a paper bag are remedies people use, with anecdotal support [6]. MedlinePlus gives similar suggestions and warns never to try neck (carotid) massage on yourself [7].
For prevention, Cleveland Clinic suggests eating and drinking more slowly, smaller portions, fewer carbonated and alcoholic drinks, and avoiding very hot or cold foods [6]. Those steps also overlap with what helps when a slower stomach makes large meals uncomfortable. If burping or heartburn comes with the hiccups, the Mounjaro® heartburn page covers that side in more detail.
Hiccups lasting longer than two days may need prescription treatment chosen according to the cause [6]. Do not change your Mounjaro® dose or schedule to stop hiccups without talking to your prescriber.
Mounjaro® is a registered trademark of Eli Lilly and Company. Wegovy® is a registered trademark of Novo Nordisk A/S. PepLabo is not affiliated with or endorsed by Eli Lilly and Company or Novo Nordisk.
When to get help
| Sign | Who to contact | How fast | Source |
|---|---|---|---|
| Severe stomach pain that will not go away, with or without vomiting, sometimes reaching the back | Stop Mounjaro® and call your prescriber right away | Today | Medication Guide [2] |
| Hiccups that make it hard to breathe, swallow or speak | Your clinician the same day, or urgent care | Today | Cleveland Clinic [6] |
| Hiccups lasting longer than two days | Your clinician | Today | Cleveland Clinic [6]; MedlinePlus [7] |
| Vomiting that keeps coming back or you cannot keep liquids down | Your prescriber | Today | Medication Guide [2] |
| Hiccups that keep returning with burping, heartburn or a sour taste | Your prescriber | At your next appointment | Medication Guide [2]; Cleveland Clinic [6] |
